BioVie raises $6M in private placement with controlling stockholder Acuitas Group

BIOVIE INC.

Sale of 3,636,364 shares at $1.65 plus warrant for 7,272,728 shares at $1.82 for aggregate $6M.
Closing expected August 15, 2022; net proceeds used for working capital.
Oppenheimer & Co. acted as sole placement agent with 3% cash fee.
Acuitas is 100% owned by chairman Terren Peizer; related-party transaction.
Existing Registration Rights Agreement to be amended to cover PIPE shares and warrant shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.